{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:36:08Z","timestamp":1780623368930,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","award":["64132481"],"award-info":[{"award-number":["64132481"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Greek Group for the Study of Inflammatory Bowel Disease","award":["2018"],"award-info":[{"award-number":["2018"]}]},{"name":"Greek Group for the Study of Inflammatory Bowel Disease","award":["2018"],"award-info":[{"award-number":["2018"]}]},{"name":"Greek Group for the Study of Inflammatory Bowel Disease","award":["2018"],"award-info":[{"award-number":["2018"]}]},{"name":"Greek Group for the Study of Inflammatory Bowel Disease","award":["2018"],"award-info":[{"award-number":["2018"]}]},{"name":"Greek Group for the Study of Inflammatory Bowel Disease","award":["2018"],"award-info":[{"award-number":["2018"]}]},{"name":"Greek Group for the Study of Inflammatory Bowel Disease","award":["2018"],"award-info":[{"award-number":["2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10620-024-08640-1","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:33:08Z","timestamp":1727299988000},"page":"3773-3785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative Colitis"],"prefix":"10.1007","volume":"69","author":[{"given":"Ioannis","family":"Drygiannakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Valatas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Filidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Tzenaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Archontoulaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"Dovrolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Kandilogiannakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kefalogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prodromos","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis E.","family":"Koutroubakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"8640_CR1","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/j.1572-0241.2008.02060.x","volume":"103","author":"IE Koutroubakis","year":"2008","unstructured":"Koutroubakis IE. Venous thromboembolism in hospitalized inflammatory bowel disease patients: the magnitude of the problem is staggering. Am J Gastroenterol. 2008;103:2281\u20132283.","journal-title":"Am J Gastroenterol."},{"key":"8640_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","volume":"18","author":"H Gordon","year":"2024","unstructured":"Gordon H, Burisch J, Ellul P et al. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2024;18:1\u201337.","journal-title":"J Crohns Colitis."},{"key":"8640_CR3","doi-asserted-by":"publisher","first-page":"13863","DOI":"10.3748\/wjg.v20.i38.13863","volume":"20","author":"P Zezos","year":"2014","unstructured":"Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol. 2014;20:13863\u201313878.","journal-title":"World J Gastroenterol."},{"key":"8640_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1572-0241.2003.04026.x","volume":"99","author":"CA Solem","year":"2004","unstructured":"Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97\u2013101.","journal-title":"Am J Gastroenterol."},{"key":"8640_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","volume":"139","author":"G Novacek","year":"2010","unstructured":"Novacek G, Weltermann A, Sobala A et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology. 2010;139:779\u2013787.","journal-title":"Gastroenterology."},{"key":"8640_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ibd.20076","volume":"13","author":"IE Koutroubakis","year":"2007","unstructured":"Koutroubakis IE, Sfiridaki A, Tsiolakidou G et al. Genetic risk factors in patients with inflammatory bowel disease and vascular complications: case-control study. Inflamm Bowel Dis. 2007;13:410\u2013415.","journal-title":"Inflamm Bowel Dis."},{"key":"8640_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1572-0241.2000.01683.x","volume":"95","author":"IE Koutroubakis","year":"2000","unstructured":"Koutroubakis IE, Sfiridaki A, Mouzas IA et al. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2000;95:190\u2013194.","journal-title":"Am J Gastroenterol."},{"key":"8640_CR8","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1023\/A:1026602803622","volume":"43","author":"IE Koutroubakis","year":"1998","unstructured":"Koutroubakis IE, Petinaki E, Anagnostopoulou E et al. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease. Dig Dis Sci. 1998;43:2507\u20132512. https:\/\/doi.org\/10.1023\/A:1026602803622","journal-title":"Dig Dis Sci."},{"key":"8640_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/j.1572-0241.2001.03846.x","volume":"96","author":"IE Koutroubakis","year":"2001","unstructured":"Koutroubakis IE. Unraveling the mechanisms of thrombosis in inflammatory bowel disease. Am J Gastroenterol. 2001;96:1325\u20131327.","journal-title":"Am J Gastroenterol."},{"key":"8640_CR10","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1111\/apt.15514","volume":"50","author":"WJ Sandborn","year":"2019","unstructured":"Sandborn WJ, Panes J, Sands BE et al. Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme. Aliment Pharmacol Ther. 2019;50:1068\u20131076.","journal-title":"Aliment Pharmacol Ther."},{"key":"8640_CR11","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jth.13336","volume":"14","author":"C Kearon","year":"2016","unstructured":"Kearon C, Ageno W, Cannegieter SC et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14:1480\u20131483.","journal-title":"J Thromb Haemost."},{"key":"8640_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/vox.12014","volume":"105","author":"Y Gao","year":"2013","unstructured":"Gao Y, Lv L, Liu S, Ma G, Su Y. Elevated levels of thrombin-generating microparticles in stored red blood cells. Vox Sang. 2013;105:11\u201317.","journal-title":"Vox Sang."},{"key":"8640_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","volume":"33","author":"DK Jeppesen","year":"2023","unstructured":"Jeppesen DK, Zhang Q, Franklin JL, Coffey RJ. Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 2023;33:667\u2013681.","journal-title":"Trends Cell Biol."},{"key":"8640_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40001-022-00792-y","volume":"27","author":"X Wu","year":"2022","unstructured":"Wu X, Xu X, Xiang Y et al. Exosome-mediated effects and applications in inflammatory diseases of the digestive system. Eur J Med Res. 2022;27:163.","journal-title":"Eur J Med Res."},{"key":"8640_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1055\/s-2006-933336","volume":"32","author":"B Osterud","year":"2006","unstructured":"Osterud B, Bjorklid E. Sources of tissue factor. Semin Thromb Hemost. 2006;32:11\u201323.","journal-title":"Semin Thromb Hemost."},{"key":"8640_CR16","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.4049\/jimmunol.1003756","volume":"186","author":"K Kambas","year":"2011","unstructured":"Kambas K, Chrysanthopoulou A, Kourtzelis I et al. Endothelin-1 signaling promotes fibrosis in vitro in a bronchopulmonary dysplasia model by activating the extrinsic coagulation cascade. J Immunol. 2011;186:6568\u20136575.","journal-title":"J Immunol."},{"key":"8640_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-020-00932-z","volume":"13","author":"D Unruh","year":"2020","unstructured":"Unruh D, Horbinski C. Beyond thrombosis: the impact of tissue factor signaling in cancer. J Hematol Oncol. 2020;13:93.","journal-title":"J Hematol Oncol."},{"key":"8640_CR18","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/cancers15051524","volume":"15","author":"N Hassan","year":"2023","unstructured":"Hassan N, Efing J, Kiesel L, Bendas G, Gotte M. The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans. Cancers (Basel). 2023;15:1524.","journal-title":"Cancers (Basel)."},{"key":"8640_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.thromres.2006.05.012","volume":"119","author":"CE Henriksson","year":"2007","unstructured":"Henriksson CE, Klingenberg O, Hellum M et al. Calcium ionophore-induced de-encryption of tissue factor in monocytes is associated with extensive cell death. Thromb Res. 2007;119:621\u2013630.","journal-title":"Thromb Res."},{"key":"8640_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/jth.12475","volume":"12","author":"M Davila","year":"2014","unstructured":"Davila M, Robles-Carrillo L, Unruh D et al. Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation? J Thromb Haemost. 2014;12:186\u2013196.","journal-title":"J Thromb Haemost."},{"key":"8640_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bcmd.2005.12.020","volume":"36","author":"B Engelmann","year":"2006","unstructured":"Engelmann B. Initiation of coagulation by tissue factor carriers in blood. Blood Cells Mol Dis. 2006;36:188\u2013190.","journal-title":"Blood Cells Mol Dis."},{"key":"8640_CR22","doi-asserted-by":"publisher","first-page":"718845","DOI":"10.3389\/fimmu.2021.718845","volume":"12","author":"A Stojanovic","year":"2021","unstructured":"Stojanovic A, Veselinovic M, Zong Y, Jakovljevic V, Pruner I, Antovic A. Increased Expression of Extracellular Vesicles Is Associated With the Procoagulant State in Patients With Established Rheumatoid Arthritis. Front Immunol. 2021;12:718845.","journal-title":"Front Immunol."},{"key":"8640_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.crohns.2012.04.008","volume":"7","author":"I Drygiannakis","year":"2013","unstructured":"Drygiannakis I, Valatas V, Sfakianaki O et al. Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis. J Crohns Colitis. 2013;7:286\u2013300.","journal-title":"J Crohns Colitis."},{"key":"8640_CR24","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/ibd\/izy204","volume":"24","author":"E Filidou","year":"2018","unstructured":"Filidou E, Valatas V, Drygiannakis I et al. Cytokine Receptor Profiling in Human Colonic Subepithelial Myofibroblasts: A Differential Effect of Th Polarization-Associated Cytokines in Intestinal Fibrosis. Inflamm Bowel Dis. 2018;24:2224\u20132241.","journal-title":"Inflamm Bowel Dis."},{"key":"8640_CR25","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1097\/01.MIB.0000435440.22484.e8","volume":"19","author":"G Bamias","year":"2013","unstructured":"Bamias G, Goukos D, Laoudi E et al. Comparative study of candidate housekeeping genes for quantification of target gene messenger RNA expression by real-time PCR in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2840\u20132847.","journal-title":"Inflamm Bowel Dis."},{"key":"8640_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1160\/TH05-06-0432","volume":"95","author":"MM Khan","year":"2006","unstructured":"Khan MM, Hattori T, Niewiarowski S, Edmunds LH, Colman RW. Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII. Thromb Haemost. 2006;95:462\u2013468.","journal-title":"Thromb Haemost."},{"key":"8640_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MBC.0000000000000876","volume":"31","author":"LG Faulkner","year":"2020","unstructured":"Faulkner LG, Alqarni S, Maraveyas A, Madden LA. Isolated tumour microparticles induce endothelial microparticle release in vitro. Blood Coagul Fibrinolysis. 2020;31:35\u201342.","journal-title":"Blood Coagul Fibrinolysis."},{"key":"8640_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.crohns.2012.05.016","volume":"7","author":"J Palkovits","year":"2013","unstructured":"Palkovits J, Novacek G, Kollars M et al. Tissue factor exposing microparticles in inflammatory bowel disease. J Crohns Colitis. 2013;7:222\u2013229.","journal-title":"J Crohns Colitis."},{"key":"8640_CR29","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1200\/JCO.2017.72.5341","volume":"35","author":"R Fonseca","year":"2017","unstructured":"Fonseca R, Cesarman-Maus G, Braggio E. Personalizing the Use of Circulating Microparticle-Associated Tissue Factor As a Biomarker for Recurrent Thrombosis in Patients With Cancer. J Clin Oncol. 2017;35:2217\u20132218.","journal-title":"J Clin Oncol."},{"key":"8640_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.thromres.2016.03.002","volume":"141","author":"C Claussen","year":"2016","unstructured":"Claussen C, Rausch AV, Lezius S et al. Microvesicle-associated tissue factor procoagulant activity for the preoperative diagnosis of ovarian cancer. Thromb Res. 2016;141:39\u201348.","journal-title":"Thromb Res."},{"key":"8640_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.trsl.2013.06.009","volume":"163","author":"J Thaler","year":"2014","unstructured":"Thaler J, Koder S, Kornek G, Pabinger I, Ay C. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation. Transl Res. 2014;163:145\u2013150.","journal-title":"Transl Res."},{"key":"8640_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2018.03.001","volume":"165","author":"Y Hisada","year":"2018","unstructured":"Hisada Y, Thalin C, Lundstrom S, Wallen H, Mackman N. Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients. Thromb Res. 2018;165:1\u20135.","journal-title":"Thromb Res."},{"key":"8640_CR33","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/ATVBAHA.117.310262","volume":"38","author":"K Stark","year":"2018","unstructured":"Stark K, Schubert I, Joshi U et al. Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo. Arterioscler Thromb Vasc Biol. 2018;38:772\u2013786.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"8640_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ygyno.2017.04.021","volume":"146","author":"JG Cohen","year":"2017","unstructured":"Cohen JG, Prendergast E, Geddings JE et al. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer. Gynecol Oncol. 2017;146:146\u2013152.","journal-title":"Gynecol Oncol."},{"key":"8640_CR35","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12885-017-3515-y","volume":"17","author":"A Fricke","year":"2017","unstructured":"Fricke A, Ullrich PV, Cimniak AFV et al. Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism. BMC Cancer. 2017;17:527.","journal-title":"BMC Cancer."},{"key":"8640_CR36","first-page":"2167","volume":"21","author":"XK Mi","year":"2017","unstructured":"Mi XK, Liu QR, Zhu L, Sang MX, Guo LR, Shan BE. Mechanism of the high coagulation state of breast cancer tissue factor. Eur Rev Med Pharmacol Sci. 2017;21:2167\u20132171.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"8640_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.thromres.2014.05.001","volume":"134","author":"D Gheldof","year":"2014","unstructured":"Gheldof D, Chatelain C, Dogne JM, Mullier F. Microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia. Thromb Res. 2014;134:213\u2013214.","journal-title":"Thromb Res."},{"key":"8640_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.thromres.2013.12.029","volume":"133","author":"J Thaler","year":"2014","unstructured":"Thaler J, Pabinger I, Sperr WR, Ay C. Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemia. Thromb Res. 2014;133:303\u2013305.","journal-title":"Thromb Res."},{"key":"8640_CR39","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.3892\/ol.2016.5105","volume":"12","author":"A Angelini","year":"2016","unstructured":"Angelini A, Miscia S, Centurione MA, Di Pietro R, Centurione L. Predictive value of microparticle-associated tissue factor activity for permeability glycoprotein-mediated multidrug resistance in cancer. Oncol Lett. 2016;12:3273\u20133277.","journal-title":"Oncol Lett."},{"key":"8640_CR40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/toxins9110376","volume":"9","author":"A Villysson","year":"2017","unstructured":"Villysson A, Tontanahal A, Karpman D. Microvesicle Involvement in Shiga Toxin-Associated Infection. Toxins (Basel). 2017;9:376.","journal-title":"Toxins (Basel)."},{"key":"8640_CR41","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.ekir.2019.07.006","volume":"4","author":"CE Mendoza","year":"2019","unstructured":"Mendoza CE, Brant EJ, McDermott ML et al. Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis. Kidney Int Rep. 2019;4:1617\u20131629.","journal-title":"Kidney Int Rep."},{"key":"8640_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2014.11.011","volume":"135","author":"S Chaturvedi","year":"2015","unstructured":"Chaturvedi S, Cockrell E, Espinola R et al. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations. Thromb Res. 2015;135:102\u2013108.","journal-title":"Thromb Res."},{"key":"8640_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.thromres.2013.11.027","volume":"133","author":"R Willemze","year":"2014","unstructured":"Willemze R, Bradford RL, Mooberry MJ, Roubey RA, Key NS. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications. Thromb Res. 2014;133:187\u2013189.","journal-title":"Thromb Res."},{"key":"8640_CR44","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/hep.27033","volume":"60","author":"PE Rautou","year":"2014","unstructured":"Rautou PE, Vion AC, Luyendyk JP, Mackman N. Circulating microparticle tissue factor activity is increased in patients with cirrhosis. Hepatology. 2014;60:1793\u20131795.","journal-title":"Hepatology."},{"key":"8640_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11239-013-1000-2","volume":"37","author":"X Zhang","year":"2014","unstructured":"Zhang X, McGeoch SC, Johnstone AM et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis. 2014;37:455\u2013463.","journal-title":"J Thromb Thrombolysis."},{"key":"8640_CR46","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/bjc.2016.170","volume":"115","author":"AJFJ Woei","year":"2016","unstructured":"Woei AJFJ, Tesselaar ME, Garcia Rodriguez P, Romijn FP, Bertina RM, Osanto S. Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis? Br J Cancer. 2016;115:332\u2013338.","journal-title":"Br J Cancer."},{"key":"8640_CR47","doi-asserted-by":"publisher","first-page":"9929461","DOI":"10.1155\/2021\/9929461","volume":"2021","author":"L Kandilogiannakis","year":"2021","unstructured":"Kandilogiannakis L, Filidou E, Drygiannakis I et al. Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and Fibrosis. Stem Cells Int. 2021;2021:9929461.","journal-title":"Stem Cells Int."},{"key":"8640_CR48","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.cardiores.2006.12.018","volume":"73","author":"B Szotowski","year":"2007","unstructured":"Szotowski B, Antoniak S, Goldin-Lang P et al. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovasc Res. 2007;73:806\u2013812.","journal-title":"Cardiovasc Res."},{"key":"8640_CR49","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1055\/s-0039-1700885","volume":"3","author":"L Papageorgiou","year":"2019","unstructured":"Papageorgiou L, Alhaj Hussen K, Thouroude S et al. Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process. TH Open. 2019;3:e340\u2013e347.","journal-title":"TH Open."},{"key":"8640_CR50","doi-asserted-by":"publisher","first-page":"9216","DOI":"10.3390\/ijms24119216","volume":"24","author":"A Wright","year":"2023","unstructured":"Wright A, Snyder OL, He H, Christenson LK, Fleming S, Weiss ML. Procoagulant Activity of Umbilical Cord-Derived Mesenchymal Stromal Cells\u2019 Extracellular Vesicles (MSC-EVs). Int J Mol Sci. 2023;24:9216.","journal-title":"Int J Mol Sci."},{"key":"8640_CR51","first-page":"893","volume":"8","author":"ON Manousos","year":"1996","unstructured":"Manousos ON, Giannadaki E, Mouzas IA et al. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol. 1996;8:893\u2013898.","journal-title":"Eur J Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08640-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T19:03:51Z","timestamp":1729278231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08640-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["8640"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08640-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The study was recommended for approval by the Bioethics Committee (decision 1599\/17\u201303-2021) and then approved by the Board of Directors (decision 277\/07\u201304-2021) of the hospital the research reported was carried into.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individuals included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participant"}},{"value":"The authors affirm that human research participants provided informed consent for publication of their anonymized health data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}